Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Melanoma 17Lung Neoplasms 6Head and Neck Neoplasms 6Pancreatic Neoplasms 5Neoplasms 5Colorectal Neoplasms 5Breast Neoplasms 5Ovarian Neoplasms 4Kidney Neoplasms 4Waldenstrom Macroglobulinemia 3Stomach Neoplasms 3Skin Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Mycosis Fungoides 3Multiple Myeloma 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Liver Neoplasms 3Glioblastoma 3Esophageal Neoplasms 3Cholangiocarcinoma 3Uterine Cervical Neoplasms 2Sezary Syndrome 2Sarcoma 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Large-Cell, Anaplastic 2

Interventions

Imatinib Mesylate 3Ipilimumab 2CTLA-4 Antigen 2trastuzumab deruxtecan 1ripretinib 1pexidartinib 1pembrolizumab 1Thalidomide 1Specimen Handling 1Nivolumab 1Magnetic Resonance Spectroscopy 1Injections 1Fentanyl 1Drug Therapy 1Docetaxel 1Cyclophosphamide 1Blood Specimen Collection 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Stromal Tumors × Drug Therapy × Dermatologic × Clear all
NCT00041808 2005-06-24

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

FeRx

Phase 1/2 Completed
20 enrolled
BreastDermatologicGastrointestinalSarcomaThoracic

Breast Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡